Posted:
12/12/2024, 12:24:06 PM
Location(s):
Massachusetts, United States ⋅ Waltham, Massachusetts, United States
Experience Level(s):
Expert or higher ⋅ Senior
Field(s):
Growth & Marketing
Workplace Type:
Remote
ABOUT US
There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers.
At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Our proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering, designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs).
Join an incredible team of innovators, disrupters, predictive modelers, and antibody engineers who embrace a shared sense of ownership, a passion to save lives, think boldly and creatively, take targeted risks, are unafraid of failure, and welcome change as a positive catalyst to new opportunities.
Be part of making a difference. Be part of Invivyd.
ABOUT US
There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers.
At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Our proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering, designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs).
Join an incredible team of innovators, disrupters, predictive modelers, and antibody engineers who embrace a shared sense of ownership, a passion to save lives, think boldly and creatively, take targeted risks, are unafraid of failure, and welcome change as a positive catalyst to new opportunities.
Be part of making a difference. Be part of Invivyd.
Position Title: Senior Manager/Associate Director, Marketing
The Senior Manager/Associate Director, Marketing, is a pivotal role on the marketing team. This person will manage all ongoing marketing activities related to access, including payer marketing material development, pull/push through material development, conference management, and field training. This role will also support access insight generation and strategy development and report to the Head of Marketing.
The Senior Manager/Associate Director, Marketing will be responsible for developing and executing marketing strategies and tactics to drive and advance patient and community engagement.
The Senior Manager/Associate Director will shape our online presence and drive marketing strategies. This position encompasses a wide range of responsibilities, from developing and executing digital marketing campaigns to analyzing performance metrics and optimizing our online strategies
Responsibilities include but are not limited to:
Market Access:
Patient Marketing
Digital Marketing
Requirements:
At Invivyd we strive to create a welcoming and inclusive environment. Here all applicants will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics.
Invivyd is proud to be an equal opportunity employer.
We do not accept unsolicited resumes from agencies.
Website: https://invivyd.com/
Headquarter Location: Waltham, Massachusetts, United States
Employee Count: 101-250
Year Founded: 2020
IPO Status: Public
Last Funding Type: Series C
Industries: Biotechnology ⋅ Pharmaceutical ⋅ Therapeutics